Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Circulating miR-1 as a potential biomarker of doxorubicin-induced cardiotoxicity in breast cancer patients
Vagner Oliveira Carvalho Rigaud, Ludmila Rodrigues Pinto Ferreira, Silvia Moreira Ayub‐Ferreira, et al.
Oncotarget (2016) Vol. 8, Iss. 4, pp. 6994-7002
Open Access | Times Cited: 107

Showing 1-25 of 107 citing articles:

A multi-organ chip with matured tissue niches linked by vascular flow
Kacey Ronaldson-Bouchard, Diogo Teles, Keith Yeager, et al.
Nature Biomedical Engineering (2022) Vol. 6, Iss. 4, pp. 351-371
Open Access | Times Cited: 278
Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the Cardio‐Oncology Study Group of the Heart Failure Association and the Cardio‐Oncology Council of the European Society of Cardiology
Radek Pudil, Christian Mueller, Jelena Čelutkienė, et al.
European Journal of Heart Failure (2020) Vol. 22, Iss. 11, pp. 1966-1983
Open Access | Times Cited: 256
Non-coding RNAs regulating mitochondrial function in cardiovascular diseases
Xiang Ao, Wei Ding, Xiaoge Li, et al.
Journal of Molecular Medicine (2023) Vol. 101, Iss. 5, pp. 501-526
Closed Access | Times Cited: 50
Cardiovascular Toxicity of Proteasome Inhibitors: Underlying Mechanisms and Management Strategies
Georgios Georgiopoulos, Nikolaos Makris, Ageliki Laina, et al.
JACC CardioOncology (2023) Vol. 5, Iss. 1, pp. 1-21
Open Access | Times Cited: 48
Doxorubicin targets multiple players: A new view of an old problem
Donato Cappetta, Francesca Rossi, Elena Piegari, et al.
Pharmacological Research (2017) Vol. 127, pp. 4-14
Closed Access | Times Cited: 162
miR-146a attenuates apoptosis and modulates autophagy by targeting TAF9b/P53 pathway in doxorubicin-induced cardiotoxicity
Jianan Pan, Yong Tang, Jianying Yu, et al.
Cell Death and Disease (2019) Vol. 10, Iss. 9
Open Access | Times Cited: 106
Role of microRNAs in doxorubicin-induced cardiotoxicity: an overview of preclinical models and cancer patients
Clarissa Ruggeri, Sonia Gioffré, Felice Achilli, et al.
Heart Failure Reviews (2017) Vol. 23, Iss. 1, pp. 109-122
Open Access | Times Cited: 92
Role of Biomarkers in Prediction of Cardiotoxicity During Cancer Treatment
Li‐Ling Tan, Alexander R. Lyon
Current Treatment Options in Cardiovascular Medicine (2018) Vol. 20, Iss. 7
Open Access | Times Cited: 88
Potential Clinical Implications of miR-1 and miR-21 in Heart Disease and Cardioprotection
Branislav Kura, Barbora Kaločayová, Yvan Devaux, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 3, pp. 700-700
Open Access | Times Cited: 86
ConsensusPathDB 2022: molecular interactions update as a resource for network biology
Atanas Kamburov, Ralf Herwig
Nucleic Acids Research (2021) Vol. 50, Iss. D1, pp. D587-D595
Open Access | Times Cited: 58
Cardiac dysfunction in cancer patients: beyond direct cardiomyocyte damage of anticancer drugs: novel cardio-oncology insights from the joint 2019 meeting of the ESC Working Groups of Myocardial Function and Cellular Biology of the Heart
Carlo G. Tocchetti, Pietro Ameri, Rudolf A. de Boer, et al.
Cardiovascular Research (2020) Vol. 116, Iss. 11, pp. 1820-1834
Open Access | Times Cited: 69
Biomarkers for Heart Failure Prognosis: Proteins, Genetic Scores and Non-coding RNAs
Apurva Shrivastava, Tina Haase, Tanja Zeller, et al.
Frontiers in Cardiovascular Medicine (2020) Vol. 7
Open Access | Times Cited: 65
Clinical Relevance of Circulating, Cell-Free and Exosomal microRNAs in Plasma and Serum of Breast Cancer Patients
Heidi Schwarzenbach
Oncology Research and Treatment (2017) Vol. 40, Iss. 7-8, pp. 423-429
Open Access | Times Cited: 64
miR-1: A comprehensive review of its role in normal development and diverse disorders
Amin Safa, Zahra Bahroudi, Hamed Shoorei, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 132, pp. 110903-110903
Open Access | Times Cited: 54
MicroRNA in the Diagnosis and Treatment of Doxorubicin-Induced Cardiotoxicity
Ziyu Kuang, Jingyuan Wu, Ying Tan, et al.
Biomolecules (2023) Vol. 13, Iss. 3, pp. 568-568
Open Access | Times Cited: 17
Circulating MicroRNA as Biomarkers of Anthracycline-Induced Cardiotoxicity
Hanne M. Boen, Martina Cherubin, Constantijn Franssen, et al.
JACC CardioOncology (2024) Vol. 6, Iss. 2, pp. 183-199
Open Access | Times Cited: 7
Fluoropyrimidine-induced cardiotoxicity
Ilaria Depetris, Donatella Marino, Alessandro Bonzano, et al.
Critical Reviews in Oncology/Hematology (2018) Vol. 124, pp. 1-10
Closed Access | Times Cited: 58
Sirt3 attenuates doxorubicin-induced cardiac hypertrophy and mitochondrial dysfunction via suppression of Bnip3.
Qiong Du, Bin Zhu, Qing Zhai, et al.
PubMed (2017) Vol. 9, Iss. 7, pp. 3360-3373
Closed Access | Times Cited: 56
Non-coding RNAs: update on mechanisms and therapeutic targets from the ESC Working Groups of Myocardial Function and Cellular Biology of the Heart
Christian Bär, Shambhabi Chatterjee, Inês Falcão‐Pires, et al.
Cardiovascular Research (2020) Vol. 116, Iss. 11, pp. 1805-1819
Open Access | Times Cited: 48
Liquid biopsy for breast cancer using extracellular vesicles and cell-free microRNAs as biomarkers
Patricia Midori Murobushi Ozawa, Tayana Schultz Jucoski, Evelyn Vieira, et al.
Translational research (2020) Vol. 223, pp. 40-60
Open Access | Times Cited: 42
Detecting early onset of anthracyclines-induced cardiotoxicity using a novel panel of biomarkers in West-Virginian population with breast cancer
Hari Vishal Lakhani, Sneha S. Pillai, Mishghan Zehra, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 40
Adjuvant breast cancer treatments cardiotoxicity and modern methods of detection and prevention of cardiac complications
Agata Bikiewicz, Maciej Banach, Stephan von Haehling, et al.
ESC Heart Failure (2021) Vol. 8, Iss. 4, pp. 2397-2418
Open Access | Times Cited: 34
Circulating Cardiovascular Biomarkers in Cancer Therapeutics‐Related Cardiotoxicity: Review of Critical Challenges, Solutions, and Future Directions
Gillian Murtagh, James L. Januzzi, Marielle Scherrer‐Crosbie, et al.
Journal of the American Heart Association (2023) Vol. 12, Iss. 21
Open Access | Times Cited: 13
MicroRNAs in the diagnosis and prevention of drug-induced cardiotoxicity
Mikuláš Skála, Barbora Hanousková, Lenka Skálová, et al.
Archives of Toxicology (2018) Vol. 93, Iss. 1, pp. 1-9
Closed Access | Times Cited: 44
Circulating MicroRNAs as Potential Predictors of Anthracycline-Induced Troponin Elevation in Breast Cancer Patients: Diverging Effects of Doxorubicin and Epirubicin
Sonia Gioffré, Mattia Chiesa, Daniela Cardinale, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 5, pp. 1418-1418
Open Access | Times Cited: 34
Page 1 - Next Page

Scroll to top